STOCK TITAN

3,750 RSU shares listed for resale by Morgan Stanley (NASDAQ: XENE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Wealth Management Canada Inc. filed a Form 144 notifying the sale of Common Shares tied to a Restricted share unit award vesting dated 03/12/2026 for 3,750 shares. The notice also lists a 03/10/2026 sale of 2,771 shares by Andrea DiFabio and a reported figure 166,559 appearing in the securities block.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records proposed resale of vested RSUs and recent sales by a holder.

The filing lists 3,750 common shares tied to a "Restricted share unit award vesting" on 03/12/2026. That phrase is the operative qualifier for the securities being offered for sale.

It also records a sale of 2,771 common shares on 03/10/2026 by Andrea DiFabio. Cash‑flow treatment and who receives proceeds are not stated in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does XENE's Form 144 disclose about the 3,750 shares?

The Form 144 lists 3,750 common shares tied to a "Restricted share unit award vesting" dated 03/12/2026. This identifies the source of the shares as vested RSUs rather than open‑market purchases or other issuances.

Who sold shares within the past three months according to the filing for XENE?

The filing shows Andrea DiFabio sold 2,771 common shares on 03/10/2026. The entry appears in the "Securities Sold During The Past 3 Months" section with an associated numeric entry of 166,559 in the securities block.

Does the Form 144 state how proceeds will be used for XENE securities?

The excerpt does not state a use of proceeds. It records the security type, source (RSU vesting), dates (03/12/2026, 03/10/2026) and share counts (3,750, 2,771) but contains no proceeds allocation or recipient details.

Which entity submitted the Form 144 filing related to XENE shares?

The filer listed is Morgan Stanley Wealth Management Canada Inc. with an address entry in Calgary and the securities are identified as Common Shares trading on NASDAQ in the excerpt.
Xenon Pharmaceut

NASDAQ:XENE

View XENE Stock Overview

XENE Rankings

XENE Latest News

XENE Latest SEC Filings

XENE Stock Data

4.82B
82.14M
Biotechnology
Pharmaceutical Preparations
Link
Canada
BURNABY